Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin in Antisocial Personality Disorder and Psychopathy
NCT05383300Completed
- Sponsor
- King's College London
- Start
- May 2017
- Primary completion
- Mar 2020
- Countries
- 1
01
Overview
Randomised, double-blind trial of oxytocin nasal spray in antisocial personality disorder (ASPD) (3 arms), sponsored by King's College London. Primary endpoint: Within-group effect of oxytocin on neural modulation of fear at 10 minutes. Started May 2017; status: completed.
02
Drugs
oxytocin nasal spray
03
Conditions
antisocial personality disorder (ASPD)
Beyond the preview
Go deeper on NCT05383300.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05383300.